Aier Eye Hospital Group Co., Ltd. (SHE:300015)
China flag China · Delayed Price · Currency is CNY
8.00
+0.01 (0.13%)
Sep 16, 2026, 3:04 PM CST

Aier Eye Hospital Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
2,5463,2403,5563,3592,5242,323
Depreciation & Amortization
1,7501,7481,5941,3471,166951.72
Other Amortization
515.71487.56352.71318.3224.17173.07
Loss (Gain) From Sale of Assets
-11.5-9.82-4.27-0.711.25-0.05
Asset Writedown & Restructuring Costs
164.4164.18194.52389.72100.34220.94
Loss (Gain) From Sale of Investments
-129.28-166.53-547.6232.9315.49343.61
Provision & Write-off of Bad Debts
133.61125.31116.31107.4477.2797.89
Other Operating Activities
564.33444.83441.84443.31203.62234.42
Change in Accounts Receivable
453.21115.22-40.75-264.53-68.21-109.44
Change in Inventory
100.423.54-85.87-168.65-159.47-37.58
Change in Accounts Payable
-494.94-239.9-877.11136.05-48.99-206.86
Change in Other Net Operating Assets
-85.094682.07145.39228.44126.8
Operating Cash Flow
5,4935,9734,8825,8724,4914,084
Operating Cash Flow Growth
0.97%22.35%-16.86%30.76%9.96%22.15%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-1,806-2,093-1,830-1,460-1,388-1,494
Sale of Property, Plant & Equipment
7.345.835.565.557.816.37
Cash Acquisitions
-299.79-621.5-1,966-1,586-1,126-945.53
Divestitures
----0.18-
Investment in Securities
-118.58-443.15729.12-305.88-795.67-250.32
Other Investing Activities
64.755.54213.2541.7542.4169.16
Investing Cash Flow
-2,153-3,096-2,848-3,304-3,260-2,514

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,6361,506863.31438.21720.32
Long-Term Debt Repaid
--2,644-1,870-1,422-2,350-1,170
Lease Payments
-1,271-1,060-899.4-821.24-662.21-457.26
Net Debt Issued (Repaid)
-1,429-1,008-364.64-559.03-1,912-449.79
Issuance of Common Stock
----3,8521,296
Repurchase of Common Stock
-42.1-38.47-46.36-576.16-5.1-3.18
Common Dividends Paid
-749.15-1,525-1,419-746.9-672.56-662.5
Other Financing Activities
-777.63-380.38-903.55-627.63-872.55-420.08
Financing Cash Flow
-2,997-2,952-2,734-2,510390.43-239.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-53.36-5.97-23.4434.8421.7110.39
Net Cash Flow
289.63-81.1-723.8192.571,6431,340

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
3,6873,8803,0524,4123,1022,590
Free Cash Flow Growth
0.47%27.15%-30.84%42.22%19.79%5.72%
Free Cash Flow Margin
16.18%17.36%14.54%21.66%19.26%17.27%
Free Cash Flow Per Share
0.400.420.330.480.340.29
Levered Free Cash Flow
2,6424,1292,5803,1072,6113,045
Unlevered Free Cash Flow
2,8064,2982,7403,2292,7223,148
Free Cash Flow After Leases
2,4152,8202,1523,5912,4402,133

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
1,9441,1361,1521,1671,0521,061
Change in Working Capital
-40.65-60.75-822.07-125.13-121.92-260.83